Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 3, 1999 CD
Six back issues from 1999 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 3 No. 1 January/February 1999 Dental Compounding
Vol. 3 No. 2 March/April 1999 Compounding for Men's Health
Vol. 3 No. 3 May/June 1999 Compounding for Animals
Vol. 3 No. 4 July/August 1999 Compounding Parenteral Products
Vol. 3 No. 5 September/October 1999 Natural Hormone Replacement Therapy
Vol. 3 No. 6 November/December 1999 Compounding for Arthritis Patients

Volume 3, 1999 CD ARTICLES

Volume3, 1999 CD ARTICLES
Title (Click for Details) Vol/Issue Page
Issues and Opportunities: Compounding for Dentistry Vol. 3 No. 1 4
Compounding Mouthwashes and Rinses for Oral Ulcerations Vol. 3 No. 1 8
Oral Ulceration Mouthwash Vol. 3 No. 1 10
Mouthwash, Toothpaste and Toothgel Vehicles Vol. 3 No. 1 12
Mouthwash/Gargle Formulation No. 1 Vol. 3 No. 1 12
Mouthwash/Gargle Formulation No. 2 Vol. 3 No. 1 12
Mouthwash/Gargle Formulation No. 3 Vol. 3 No. 1 12
Toothgel Vehicle Vol. 3 No. 1 13
Toothpaste Vehicle Vol. 3 No. 1 13
Toxicity of Amalgams Vol. 3 No. 1 14
A Brief Look at the History of Oral Hygiene Vol. 3 No. 1 17
Dental Compounding in Denmark Vol. 3 No. 1 18
The Basics of Compounding: Compounding Ointments and Pastes Vol. 3 No. 1 22
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Vol. 3 No. 1 25
Coenzyme Q10: It's Everywhere Vol. 3 No. 1 30
Ubidicarenone (Coenzyme Q10) 200-mg Gelatin Troche Vol. 3 No. 1 32
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor Vol. 3 No. 1 34
Audit Problems for Compounding Pharmacies Vol. 3 No. 1 36
HRT Marketing Tip Vol. 3 No. 1 37
Ringworms in Cats Vol. 3 No. 1 38
Profile of a Practice Vol. 3 No. 1 39
Dental Cavity Varnish Vol. 3 No. 1 42
Dental Chemical Curettage Agent Vol. 3 No. 1 43
Dental Pressure Indicating Paste (PIP) Vol. 3 No. 1 44
Fluoride Lozenges Vol. 3 No. 1 45
Gag Tablet Vol. 3 No. 1 46
Gum Massage Gel Vol. 3 No. 1 47
Misoprostol 0.0024% and Lidocaine 1% in Glycerin Mouth Paint Vol. 3 No. 1 48
Misoprostol Mucoadhesive Anesthetic Powder Vol. 3 No. 1 49
Potassium Nitrate Desensitizing Gel Vol. 3 No. 1 50
Tetracycline 2.4% or Metronidazole 10% Periodontal Gel Vol. 3 No. 1 51
Antioxidants, Featured Excipient: Vol. 3 No. 1 52
Standard Operating Procedure for Performing Physical Quality Assessment of Suppositories, Troches, Lollipops and Sticks Vol. 3 No. 1 56
Calculations Vol. 3 No. 1 58
Stability of Four Commercial Products Delivered by Mail Order Vol. 3 No. 1 59
Y-Site Stability of Fosphenytoin and Sodium Phenobarbital Vol. 3 No. 1 64
Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature Vol. 3 No. 1 67
Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis Vol. 3 No. 2 76
Male Impotency and the Compounding Pharmacist Vol. 3 No. 2 80
Medication Combinations for Penile Injections Vol. 3 No. 2 81
Complementary Medical Approaches to Benign Prostatic Hyperplasia Vol. 3 No. 2 85
Natural Testosterone: Hormone of the Heart Vol. 3 No. 2 88
Use of Saw Palmetto and Pygeum in Men Vol. 3 No. 2 99
Case Report: Testosterone Supplementation in a Vasectomy Patient Vol. 3 No. 2 101
An Aftershave Lotion for Pseudofolliculitis Barbae Vol. 3 No. 2 102
Compounding for Athletes: A Primer for Rookies Vol. 3 No. 2 104
Book Reviews Vol. 3 No. 2 107
Natural HRT: Corrective Measures When the System Goes Down Vol. 3 No. 2 109
The Basics of Compounding: Compounding Creams and Lotions Vol. 3 No. 2 111
Profile of a Practice Vol. 3 No. 2 116
Tips for Collecting Mortars and Pestles Vol. 3 No. 2 118
Personal Computing: Take Care When Choosing a Computer Consultant Vol. 3 No. 2 122
Report: USP Expert Advisory Panel on Pharmacy Compounding Practices Vol. 3 No. 2 126
Marketing Tip: Locator Maps Vol. 3 No. 2 127
Athletic-Analgesic Rub Vol. 3 No. 2 130
Dehydroepiandrosterone 50-mg Capsules Vol. 3 No. 2 131
Minoxidil 3% and Finasteride 0.1% Topical Liquid Vol. 3 No. 2 132
Piroxicam 0.5% in Pluronic Lecithin Organogel Vol. 3 No. 2 133
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection Vol. 3 No. 2 134
Sildenafil Citrate 25-mg Sublingual Troches Vol. 3 No. 2 135
Special Aftershave Preparations Vol. 3 No. 2 136
Testosterone-Menthol Eutectic Ointment (2% Testosterone) Vol. 3 No. 2 137
Testosterone 10-mg Troches Vol. 3 No. 2 138
Testosterone 10-mg/0.1-mL Sublingual Drops Vol. 3 No. 2 139
Preservatives, Featured Excipient: Vol. 3 No. 2 142
Calculations Vol. 3 No. 2 145
Standard Operating Procedure for Quality Assessment of Oral and Topical Liquids Vol. 3 No. 2 146
Analysis of Extemporaneous Alprostadil Formulations Vol. 3 No. 2 148
Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags Vol. 3 No. 2 156
Quantitation of Testosterone Propionate in an Injection Using High Performance Liquid Chromatography Vol. 3 No. 2 158
In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1 Vol. 3 No. 2 160
Compounding and the Specialty Veterinary Practice: An Interview with Gary Riggs, DVM, ABVP Vol. 3 No. 3 172
Call of the Wild: Compounding for Zoos and Exotics Vol. 3 No. 3 176
Improving Profitability with Veterinary Compounding Vol. 3 No. 3 180
Compounding for Creatures: What Works Vol. 3 No. 3 182
The Top Ten Veterinary Compound Preparations Vol. 3 No. 3 183
Veterinary Flavor Suggestions Vol. 3 No. 3 186
When is Compounding for Animals Legal? Vol. 3 No. 3 188
Use of Fenbendazole in Treating Trichuriasis in Colobus Monkeys Vol. 3 No. 3 193
Returning to our Roots Vol. 3 No. 3 194
Value and Pricing: Figuring Out What You're Worth Vol. 3 No. 3 197
Marketing Tip: Teachable Moments: A Simple Concept Vol. 3 No. 3 199
The BPS Pharmacy Specialty Certification Program Vol. 3 No. 3 200
Compounding for Athletes: Tips for Making the Team Vol. 3 No. 3 206
The Basics of Compounding: Compounding Powder-Filled Capsules Vol. 3 No. 3 209
Morphine Sulfate-Dextromethorphan Hydrobromide-Example of capsule with Dry Powder Fill Vol. 3 No. 3 215
Amitriptyline HCl 1-mg/mL Oral Liquid and Gel Vol. 3 No. 3 218
Buspirone HCl 2.5-mg/0.1-mL in PLO for Cats Vol. 3 No. 3 219
General Sulfonamide 150-mg/mL Suspension Vol. 3 No. 3 220
Nonaqueous Nonoleaginous Paste Base Vol. 3 No. 3 221
Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs Vol. 3 No. 3 222
Progesterone 100-mg/mL Veterinary Injection Vol. 3 No. 3 223
Sulfadiazine Sodium 333-mg/mL and Pyrimethamine 16.7-mg/mL Oral Liquid Vol. 3 No. 3 224
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop Vol. 3 No. 3 225
Veterinary Electrolyte Injection Vol. 3 No. 3 226
Veterinary Phenobarbital 22-mg/mL Oral Liquid Vol. 3 No. 3 227
Sweetening Agents, Featured Excipient: Vol. 3 No. 3 228
Standard Operating Procedure for Quality Assessment of Powder-Filled, Hard-Gelatin Capsules Vol. 3 No. 3 232
Calculations Vol. 3 No. 3 234
Fosphenytoin Y-site Stability Studies with Lorazepam and Midazolam Hydrochloride Vol. 3 No. 3 235
Quantitation of Testosterone in Suspension using High Performance Liquid Chromatography Vol. 3 No. 3 239
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Vol. 3 No. 3 241
Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding Vol. 3 No. 4 253
Green IV Nutritionals Vol. 3 No. 4 260
Sterilization and Depyrogenation Principles and Methods Vol. 3 No. 4 263
Book Review-The CIVAS Handbook Vol. 3 No. 4 269
Sterile Product Compounding: A Comparison of ASHP and USP Guidelines Vol. 3 No. 4 270
Extemporaneous Formulations in Pediatric Patients Vol. 3 No. 4 274
Marketing Tip: PR Can Help with Image Change and Geographic Expansion Vol. 3 No. 4 277
Antique Pharmaceutical Balances Vol. 3 No. 4 280
Compounding for Athletes: Common Questions about Sports Medicine Vol. 3 No. 4 285
Profile of a Practice Vol. 3 No. 4 288
The Basics of Compounding: Compounding Special Capsules Vol. 3 No. 4 291
Capsules with Liquid Fill-Sample-Progesterone 100-mg Vol. 3 No. 4 294
Capsules with Semisolid Fill-Sample-Tri-Est Vol. 3 No. 4 294
Calcium Levulinate 15-mg/mL Injection Vol. 3 No. 4 298
Dextrose 20% and Sodium Chloride 20% Sclerosing Injection Vol. 3 No. 4 299
Estradiol 5-mg/mL-in-Oil Injection Vol. 3 No. 4 300
Fentanyl 20-mcg/mL and Bupivacaine HCl 1.25-mg/mL for Pump Administration Vol. 3 No. 4 301
Morphine Sulfate 50-mg/mL Injection Vol. 3 No. 4 302
Parenteral Admixture with Y-Site Administration Vol. 3 No. 4 303
Tri-Est 2.5-mg/mL Aqueous Injection Vol. 3 No. 4 304
Trimethoprim 50-mg/mL Injection Vol. 3 No. 4 305
Vancomycin and Ceftazidime in Peritoneal Dialysis Solution Vol. 3 No. 4 306
Veterinary Prochlorperazine and Isopropamide Injection Vol. 3 No. 4 307
Acidifying Agents, Featured Excipient: Vol. 3 No. 4 309
Calculations Vol. 3 No. 4 311
Standard Operating Procedure for Quality Assessment of Special Hard-Gelatin Capsules Vol. 3 No. 4 312
Quantitation of Testosterone-Cypionate-in-Oil Injection using High Performance Liquid Chromatography Vol. 3 No. 4 314
Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution Vol. 3 No. 4 316
Rapid Pharmacokinetic Evaluation of Topical Drug Formulations Vol. 3 No. 4 321
Interview: Katharina Dalton, MD: Progesterone and Related Topics Vol. 3 No. 5 332
Finding the Balance Vol. 3 No. 5 340
Top Ten HRT Compound Preparations Vol. 3 No. 5 342
Wilson's Syndrome and T3 Therapy Vol. 3 No. 5 344
Assessment and Management of Thermoregulation Vol. 3 No. 5 350
Case Reports: Long-Term Effects of Topical Progesterone Cream Application; Progesterone Suppositories for PMS Vol. 3 No. 5 352
Andropause: Annotated Citations from the Literature Vol. 3 No. 5 355
Women's Health Book Reviews Vol. 3 No. 5 357
Planning and Marketing a Natural HRT Patient Seminar Vol. 3 No. 5 360
Marketing Tip: Collaboration Can Result in More Cost-Effective Seminars Vol. 3 No. 5 362
Preventing Leakage in Oil-Filled Capsules Vol. 3 No. 5 364
Feline Urologic Syndrome and Diet Formulation Vol. 3 No. 5 366
Compounding Practice Structures Vol. 3 No. 5 368
Closing in on 2000: Your Y2K Report Vol. 3 No. 5 371
Chemical Facial Peel Formulations: an Overview Vol. 3 No. 5 375
Jessner's Solution Vol. 3 No. 5 375
Unna's Paste Vol. 3 No. 5 375
Baker-Gordon Formula Vol. 3 No. 5 376
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids Vol. 3 No. 5 380
Tamoxifen Citrate Cream 0.1% Vol. 3 No. 5 381
Compounding for Athletes: Successful Sports Compounds Vol. 3 No. 5 382
The Basics of Compounding: Compounding Gels Vol. 3 No. 5 385
Lubricating Jelly Formula Vol. 3 No. 5 388
Poloxamer Gel Base Vol. 3 No. 5 388
Clear Carbomer Gel Vol. 3 No. 5 388
Piroxicam 0.5% in an Alcoholic Gel Vol. 3 No. 5 389
Methylcellulose Gels Vol. 3 No. 5 389
Pluronic Lecithin Organogel (PLO Gel) Vol. 3 No. 5 389
Estriol 0.2-mg/mL in Pluronic Lecithin Organogel Vol. 3 No. 5 392
Ethinyl Estradiol 0.2-mg Gelatin Troches Vol. 3 No. 5 393
Progesterone 50-mg/mL Topical Gel Vol. 3 No. 5 394
Progesterone 100-mg/mL Sublingual Drops Vol. 3 No. 5 395
Progesterone 100-mg Semisolid-Fill, Hard-Gelatin Capsules Vol. 3 No. 5 396
Progesterone 10% Topical Cream Vol. 3 No. 5 397
Progesterone 200-mg/mL in Pluronic Lecithin Organogel Vol. 3 No. 5 398
Testosterone 1-mg Buccal Troches Vol. 3 No. 5 399
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules Vol. 3 No. 5 400
Triple Estrogen 2.5-mg Slow-Release Capsules Vol. 3 No. 5 401
Alkalizing Agents, Featured Excipient: Vol. 3 No. 5 404
Standard Operating Procedure: Quality Assessment for Injectable Solutions Vol. 3 No. 5 406
Calculations Vol. 3 No. 5 408
In Vitro Studies on the Release of Morphine Sulfate from Compounded Slow-Release Morphine-Sulfate Capsules Vol. 3 No. 5 409
Stability of Dobutamine Hydrochloride 4 mg/mL in 5% Dextrose Injection at 5 and 23 degrees C Vol. 3 No. 5 412
Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II Vol. 3 No. 5 415
Glucosamine Sulfate: A Review of Efficacy for the Pharmacy Professional Vol. 3 No. 6 428
Osteoarthritis: Other Options Vol. 3 No. 6 433
Book Reviews: Maximizing the Arthritis Cure: A Step-by-Step Program To Faster, Stronger Healing During Any Stage of the Cure Vol. 3 No. 6 438
Book Reviews: The Arthritis Cure: The Medical Miracle that Can Halt, Reverse, and May Even Cure Osteoarthritis Vol. 3 No. 6 438
Electronically Controlled Drug Delivery Vol. 3 No. 6 439
Case Reports for Arthritis Issue: Iontophoresis with Lidocaine and Dexamethasone for Treating Rotator Cuff Injury in a Hockey Player Vol. 3 No. 6 441
Iontophoresis and Phonophoresis for Treating Epicondylitis Vol. 3 No. 6 441
Compounding Radiolabeled Blood Cells for Diagnostic Imaging Vol. 3 No. 6 443
Extemporaneous Formulations: How to Evaluate HPLC Stability Studies Vol. 3 No. 6 447
Marketing Tip: Flavors: Target Marketing to Doctors and Patients Vol. 3 No. 6 454
Book Reviews: Hatherleigh Guide to Psychopharmacology Vol. 3 No. 6 454
Book Reviews: Medical Abbreviations: 14,000 Conveniences at the Expense of Communications and Safety Vol. 3 No. 6 454
Profile of a Practice: Going the Extra Mile with Pharmaceutical Care Vol. 3 No. 6 455
Independent Pharmacists Score High with Consumers Vol. 3 No. 6 457
When Problem Audits Strike Vol. 3 No. 6 458
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops Vol. 3 No. 6 461
Linguet Base (Soft Lozenge) Vol. 3 No. 6 462
Sorbitol Based Hard Lozenges Vol. 3 No. 6 462
Sucrose Based Hard Lozenges Vol. 3 No. 6 462
Polyethylene Glycol (PEG) Troches (Soft Lozenges) Vol. 3 No. 6 463
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) Vol. 3 No. 6 463
Chewable Lozenges Vol. 3 No. 6 464
Capsicum and Capsaicin Formulas Vol. 3 No. 6 468
DMSO 70% Topical Solution Vol. 3 No. 6 469
Glucosamine HCl 600-mg Capsules Vol. 3 No. 6 470
Indomethacin 4% Topical Spray Vol. 3 No. 6 471
Iontophoresis Solutions for Arthritis Vol. 3 No. 6 472
Ketoprofen 2.5% in Pluronic Lecithin Organogel Vol. 3 No. 6 473
Methotrexate 2.5-mg/5-mL Oral Liquid Vol. 3 No. 6 474
Methyl Salicylate and Menthol Analgesic Stick Vol. 3 No. 6 475
Piroxicam 1% Alcoholic Gel Vol. 3 No. 6 476
Ultrasonic Preparations for Arthritis Vol. 3 No. 6 477
Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient: Vol. 3 No. 6 479
Calculations Vol. 3 No. 6 487
Operation of a Dry-Heat Sterilizing Oven and Validation of this Procedure Vol. 3 No. 6 488
Calamine Lotion: Experimenting with a New Suspending Agent Vol. 3 No. 6 490
Use of an Oxygen Extractor to Minimize Oxidation of Compounded Preparations Vol. 3 No. 6 493
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Vol. 3 No. 6 496